Features on drug dependence testing and initiatives related to marmoset testing projects are published.
"INA NOTES December 2016 No.4" is a publication by Inari Research Co., Ltd., which conducts safety testing and pharmacological efficacy testing for the development of pharmaceuticals, medical devices, pesticides, food, and other chemical substances. This publication includes the latest technology information, a feature on drug dependence testing, and initiatives related to marmoset testing, presented with diagrams and photographs. [Contents] ■ SEND NEWS ■ Latest Technology Information ■ Feature: Drug Dependence Testing ■ Series: Initiatives in Marmoset Testing ■ TOPICS ■ Announcements *The downloadable version is a "Digest Edition." If you would like the "Complete Edition," please feel free to contact us.
Inquire About This Product
basic information
**Publication Content (Excerpt)** ■SEND NEWS - 4th Hamamatsu Toxicity Testing Forum Held - Realization of Speed through the Introduction of Tran SEND ■Latest Technology Information - Effects of Transdermal Administration on Embryonic and Fetal Development in Rats ■Feature: Drug Dependence Testing - Formation of Physical Dependence on Diazepam through Oral Administration in Rats and Its Blood Concentration *The downloadable version is a "Digest Version." If you would like the "Complete Version," please feel free to contact us.*
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the brochure or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
Our company is located in the nature-rich city of Ina, Nagano Prefecture, surrounded by two Alps, and has been serving our customers as a non-clinical trial contract research organization (CRO) for 50 years. Since 2022, we have become a member of the Shin Nippon Science Group, expanding and enhancing our contract testing items and analyses, and we can quickly respond to the procurement of various testing materials (such as animals). Non-Clinical Trial Business We accept safety and efficacy testing for pharmaceuticals, chemicals, pesticides, food, medical devices, and more. We conduct in vivo tests using small animals, rabbits, dogs, and monkeys, as well as in vitro tests using bacteria and cells, and various alternative method tests. Additionally, we specialize in the creation of SEND data required for FDA applications for new drugs, and we also undertake work related to SEND conversion and QC for data creation and conversion only. Our facility was the first in Japan to obtain full accreditation from AAALAC International (the Association for Assessment and Accreditation of Laboratory Animal Care International), and we are committed to international standards of animal welfare. We also propose tests necessary for various applications and registrations in compliance with regulations in different countries and regions.